BIOMEDICINES 润色咨询

Biomedicines

出版年份:暂无数据 年文章数:3690 投稿命中率: 开通期刊会员,数据随心看

出版周期:Q 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    17小时前 ms9000000402523044 来自上海

    试试看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-12-10 ms5000001127810224 来自浙江省

    审稿速度:1.0
    经验分享:pending review已经10天了

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-11-04 ms3000000019971711 来自上海

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:脑
    经验分享:mjjk

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-03-01 908919352 来自重庆

    投出了,中了,必来还愿

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-03-06 ms8000000077636074

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:骨科非肿瘤
    经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-09-20 ms8000000357353268 来自江苏省

    偏重的研究方向:肿瘤;生物学
    经验分享:Under review 13天了,大家都多久啊?急。。。

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-03-02 ms7000002142912750 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:医学
    经验分享:很快接受

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-09-08 122981b1m10暂无昵称 来自广东省

    这个还收生信+简单的验证吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2021-09-14 1de65763m65(暂无匿称)

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0
    偏重的研究方向:miRNAs;cancer;Bioinformatics
    经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2190946, encodeId=ef9c21909460c, content=试试看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305d9183308, createdName=ms9000000402523044, createdTime=Mon Mar 04 15:22:17 CST 2024, time=17小时前, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2174017, encodeId=b5c321e40172b, content=审稿速度:1.0<br>经验分享:pending review已经10天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdd38463891, createdName=ms5000001127810224, createdTime=Sun Dec 10 12:46:04 CST 2023, time=2023-12-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166704, encodeId=7ca82166e0442, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:脑<br>经验分享:mjjk<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b5612327, createdName=ms3000000019971711, createdTime=Sat Nov 04 21:58:03 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2117090, encodeId=e40c211e09023, content=投出了,中了,必来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fba12754290, createdName=908919352, createdTime=Wed Mar 01 17:40:38 CST 2023, time=2023-03-01, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2118021, encodeId=c83421180219e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:骨科非肿瘤<br>经验分享:第一次小修后三个审稿人只有两个提出很少的建议,经过第二次小修,上个月15号投稿,目前状态Pengding editor decision,请问各位同门,这种状况大概要持续多久?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0e56412258, createdName=ms8000000077636074, createdTime=Mon Mar 06 23:12:33 CST 2023, time=2023-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158726, encodeId=55592158e26f6, content=偏重的研究方向:肿瘤;生物学<br>经验分享:Under review 13天了,大家都多久啊?急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8e08290970, createdName=ms8000000357353268, createdTime=Wed Sep 20 15:57:18 CST 2023, time=2023-09-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2117230, encodeId=a95c211e230aa, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:医学<br>经验分享:很快接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434e5646774, createdName=ms7000002142912750, createdTime=Thu Mar 02 14:40:52 CST 2023, time=2023-03-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156719, encodeId=bc7b2156e191f, content=这个还收生信+简单的验证吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d23b2343857, createdName=122981b1m10暂无昵称, createdTime=Fri Sep 08 15:47:40 CST 2023, time=2023-09-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1051079, encodeId=63de10510e92b, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向:miRNAs;cancer;Bioinformatics<br>经验分享:初审14天,两个审稿人30条意见,要求加数据重新计算,大修给了10天时间,已经修回,正在等待结果. 总体感觉还是比较严格的,并没有有些人说的那么水,文章还是要有创新性. 2000瑞士法郎的版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b201694006, createdName=1de65763m65(暂无匿称), createdTime=Tue Sep 14 12:15:29 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152244, encodeId=c01521522447e, content=这个杂志怎么样?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1912628487, createdName=2007007, createdTime=Fri Aug 11 11:59:05 CST 2023, time=2023-08-11, status=1, ipAttribution=堪萨斯)]
    2023-08-11 2007007 来自堪萨斯

    这个杂志怎么样?

    0

共63条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分